FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

414805007: Natalizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2531793014 Natalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2535349018 Natalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2531793014 Natalizumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2531793014 Natalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2535349018 Natalizumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2535349018 Natalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51821000195115 natalizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66101000195116 Natalizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
827271000172117 natalizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
827271000172117 natalizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
51821000195115 natalizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66101000195116 Natalizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Natalizumab (substance) Is a Alpha-4 integrin receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Is a agent contre une maladie inflammatoire de l'intestin false Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Has disposition Alpha-4 integrin receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Is a Gastrointestinal agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Natalizumab (substance) Is a Immunosuppressant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing natalizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Natalizumab 300mg injection solution 15mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely natalizumab 300 milligram/15 milliliter conventional release solution for injection vial Has precise active ingredient False Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely natalizumab 300 milligram/15 milliliter conventional release solution for injection vial Has basis of strength substance (attribute) False Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Natalizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only natalizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only natalizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Natalizumab 20 mg/mL solution for injection Has basis of strength substance (attribute) True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Natalizumab 20 mg/mL solution for injection Has precise active ingredient True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Natalizumab therapy Direct substance True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely natalizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely natalizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Natalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start